Shaperon

Shaperon is a clinical-stage biotech company that develops inflammasome inhibitors.

Based based in Asia-Pacific (APAC), Shaperon works in biopharma, biotechnology, founded in 2008.

As a business in biopharma, biotechnology, Shaperon is listed here with the public details available about it.

Its base of operations is Asia-Pacific (APAC).

Its current recorded stage is Series_C.

The company reports a headcount in the c_00011_00050 range.

It has disclosed roughly $26B in funding.

Website: shaperon.com